Another therapeutic alternative that is being studied is the use of gluten digesting enzymes such as prolyl-endopeptidase which is derived from the Aspergillus Niger fungus. It is said to be capable of degrading gluten protein into fragments safe for celiac patients.
Otra de las alternativas terapéuticas más estudiada es el uso de enzimas capaces de digerir el gluten, como la procedente del hongo Aspergillus Niger, denominada prolil-endopeptidasa capaz de degradar el gluten en fragmentos proteicos inocuos para los pacientes celíacos.